135 related articles for article (PubMed ID: 1107251)
1. [Immunosuppression: bioligical bases and usage].
Wilmanns W
Internist (Berl); 1975 Oct; 16(10):451-9. PubMed ID: 1107251
[No Abstract] [Full Text] [Related]
2. [Immunosuppression by means of antilymphocyte serums in humans].
Revillard JP
Nouv Rev Fr Hematol; 1972; 12(2):129-37. PubMed ID: 4264610
[No Abstract] [Full Text] [Related]
3. [Basis of immunosuppressive effect of D-penecillamine].
Schumacher K
Internist (Berl); 1975 Oct; 16(10):460-5. PubMed ID: 1107252
[No Abstract] [Full Text] [Related]
4. [Current trends in the study of immunosuppressive agents].
Uteshev BS
Farmakol Toksikol; 1981; 44(1):5-12. PubMed ID: 6455303
[TBL] [Abstract][Full Text] [Related]
5. The virtue of tolerance.
Check E
Nature; 2002 Jul; 418(6896):364-6. PubMed ID: 12140530
[No Abstract] [Full Text] [Related]
6. [Assessment of the effect of immunosuppression on leukocyte migration inhibition in various autoimmune diseases in children].
Lukas A; Cesarz E; Sliwa F; Lukas W; Sychłowy A
Pediatr Pol; 1978 Nov; 53(11):1271-5. PubMed ID: 309586
[No Abstract] [Full Text] [Related]
7. [Possibilities and current trends of biological immunosuppression in organ and tissue transplantation. I].
Păuşescu E
Microbiol Parazitol Epidemiol (Bucur); 1973; 18(5):437-58. PubMed ID: 4588358
[No Abstract] [Full Text] [Related]
8. Lessons for transplant immunosuppression from the usage of cyclosporine in autoimmune diseases.
Bach JF
Transplant Proc; 1994 Oct; 26(5):3077-81. PubMed ID: 7940966
[No Abstract] [Full Text] [Related]
9. [T- and B-lymphocytes].
Petrov RV; Cheredeev AN
Usp Sovrem Biol; 1974; 77(1):90-105. PubMed ID: 4619259
[No Abstract] [Full Text] [Related]
10. Interspecies comparison of the immunosuppressive efficacy and safety of FK 506.
Thomson AW
Transplant Proc; 1990 Feb; 22(1):100-5. PubMed ID: 1689883
[No Abstract] [Full Text] [Related]
11. [Immunosuppressive therapy in auto-immune diseases i. general fundamentals (author's transl)].
Sönnichsen N; Alberecht-Nebe H; Schulze P; Apostoloff E
Dermatol Monatsschr; 1978 Nov; 164(11):769-78. PubMed ID: 363471
[No Abstract] [Full Text] [Related]
12. Immunosuppression and immunomodulation.
Goust JM; Stevenson HC; Galbraith RM; Virella G
Immunol Ser; 1990; 50():481-98. PubMed ID: 2091765
[No Abstract] [Full Text] [Related]
13. [Chemotherapy and immunosuppression].
Cleton FJ
Ned Tijdschr Geneeskd; 1977 Jan; 121(1):18-21. PubMed ID: 834323
[No Abstract] [Full Text] [Related]
14. Leflunomide, an immunorestoring drug for the therapy of autoimmune disorders, especially rheumatoid arthritis.
Bartlett RR; Brendel S; Zielinski T; Schorlemmer HU
Transplant Proc; 1996 Dec; 28(6):3074-8. PubMed ID: 8962190
[No Abstract] [Full Text] [Related]
15. [Immunologic and pharmacological principles for the use of immunosuppressive drugs in autoimmune diseases].
Floersheim GL
Schweiz Med Wochenschr; 1970 Dec; 100(52):2241-7. PubMed ID: 4946978
[No Abstract] [Full Text] [Related]
16. Posttransplant immunologic monitoring: summation.
Dossetor JB; Myburgh JA
Transplant Proc; 1978 Sep; 10(3):661-70. PubMed ID: 309673
[No Abstract] [Full Text] [Related]
17. Immunosuppression in cardiac transplantation.
Rose EA; Addonizio LJ
Bibl Cardiol; 1988; (43):1-9. PubMed ID: 3067706
[No Abstract] [Full Text] [Related]
18. Anesthesia and immunology.
Duncan PG; Cullen BF
Anesthesiology; 1976 Nov; 45(5):522-38. PubMed ID: 1086067
[No Abstract] [Full Text] [Related]
19. [Immunological aspects of malignant lymphomas].
Hancock BW; Richmond J
Recenti Prog Med; 1978 Feb; 64(2):217-29. PubMed ID: 347546
[No Abstract] [Full Text] [Related]
20. The primacy of humoral antibody (complement-dependent cytotoxicity and antibody-dependent cellular cytotoxicity) in concordant xenograft rejection.
Araneda D; Thomas FT; Ljung T; Cekada E; Pittman K
Transplant Proc; 1995 Feb; 27(1):268-9. PubMed ID: 7878997
[No Abstract] [Full Text] [Related]
[Next] [New Search]
